Abstract
Background

Subjective cognitive decline (SCD), an early indicator of cognitive impairment, may affect COPD care and outcomes, yet its sociodemographic associations in Chronic Obstructive Pulmonary Disease (COPD) remain poorly understood.

Objective

To investigate the prevalence of SCD among people with COPD across different age groups and identify associations between demographics, risk behaviors, comorbidities, and self-reported SCD.

Design

Pooled 2019 BRFSS data from 24 states using the Cognitive Decline module were analyzed. Logistic regression assessed relationships between demographics, behaviors, comorbidities, and SCD, adjusting for confounders.

Participants

A total of 12,003 adults with COPD aged ≥ 45 were included in the study (weighted population = 617,792).

Main Measures

Prevalence of SCD, associations with demographics, behaviors, health status, income, employment, and smoking.

Key Results

Among adults with COPD, 24.1% reported SCD. The prevalence among those with SCD was highest in those aged 55–64 (30.2%), followed by 65–74 (24.5%) and 45–54 (23.1%). Older age (55 to 64: AOR = 0.63, 95% CI: 0.49 – 0.80; 65 to 74: AOR = 0.54, 95% CI: 0.40 – 0.72; 75 to 79: AOR = 0.41, 95% CI: 0.29 – 0.60; 80 + : AOR = 0.47, 95% CI: 0.32 – 0.69) and higher annual income (e.g., $25,000 to $49,999: AOR = 0.80, 95% CI: 0.65 – 0.99; $50,000 to $74,999: AOR = 0.68, 95% CI: 0.51 – 0.91) were associated with lower odds of reporting SCD, while unemployment (AOR = 1.73, 95% CI: 1.33 – 2.27), history of stroke (AOR = 1.35, 95% CI: 1.05 – 1.74), and fair or poor health (AOR = 0.47, 95% CI: 0.39 – 0.57) were linked to higher odds of reporting SCD.

Conclusions

Among adults with COPD, the prevalence of SCD varied by age, with the highest rates in those aged 55–64, and was independently associated with socioeconomic factors and health risks, emphasizing the complex interplay of demographic and health-related factors in SCD.

Topic

JGIM

Author Descriptions

Department of Health Science, The University of Alabama, Tuscaloosa, AL, USA
Michael L. Stellefson PhD, MCHES®, Isabelle M. Boyd BSPH, Sarah M. Flora MS & Olivia K. Campbell

Department of Behavioral and Community Health, School of Public Health, University of Maryland, College Park, MD, USA
Min Qi Wang PhD

Department of Psychiatry and Iowa Neuroscience Institute, University of Iowa, Iowa City, IA, USA
Karin F. Hoth PhD

Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, University of California San Francisco, San Francisco, CA, USA
Leah J. Witt MD & Angela O. Suen MD

Division of Geriatrics, Department of Medicine, University of California San Francisco, San Francisco, CA, USA
Leah J. Witt MD & Ashwin A. Kotwal MD, MS

Palliative, and Extended Care Service Line, San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA
Ashwin A. Kotwal MD, MS

Division of Pulmonary and Critical Care Medicine, Department of Health Policy and Management, University of California, Los Angeles, CA, USA
Russell G. Buhr MD, PhD

Department of Medicine, Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, CA, USA
Russell G. Buhr MD, PhD

Division of Pulmonary, Allergy, and Critical Care Medicine and School of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA
Anand S. Iyer MD, MSPH

Share